A two-arm, multicenter exploratory clinical study of anrotinib combined with piemprizumab and crapy in first-line treatment hemotheof metastatic colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Interventions: Group A:Sequential therapy with arotinib, oxaliplatin, capecitabine, and paclitaxel;Group B:Simultaneous treatment with arotinib + oxaliplatin + capecitabine + paiampilizumab Primary outcome(s): ORR Study Design: Non randomized control
创建时间：
2022-05-15
